Projects per year
Personal profile
Biography
Graduated from the University of Cambridge in 2012 including an intercalated degree in Pharmacology (1st). He then undertook a Respiratroy Academic Foundation Job affiliated with the University of East Anglia and NHS Norfolk and Norwich. During these 2 years he obtained his MRCP(UK).
Following his Foundation Years, Mark worked for a year in Canberra, Australia. He obtained registration with the Australian Medical Council and retains registration. He returned to Scotland to undertake Core Medical Training, including a rotation at the Beatson West of Scotland Cancer Centre.
He began Specialty training in Medical Oncology in 2017 before taking up a SCREDS Clinical Lectureship with Prof Petty at the University of Dundee. He obtained CSO funding to undertake a 3 year PhD focussed on frailty in advanced gastroesophageal cancer and began this in August 2020.
Research
CSO Clinical Academic Fellow
Vice chairman of NOTCH (National Oncology Trainee Collaborative for Healthcare Research)
Research interests
Frailty in advanced cancer
Biomarkers for chemosensitivity
Supportive care
Quality of life
Education/Academic qualification
PGCert THE
Award Date: 1 May 2018
Doctor of Medicine, University of Cambridge
Award Date: 27 Jun 2012
Bachelor of Arts, University of Cambridge
1 Oct 2006 → 30 Jun 2009
Award Date: 30 Jun 2009
External positions
Medical Oncology Registrar, NHS Tayside
10 Sep 2018 → …Keywords
- RC0254 Neoplasms. Tumors. Oncology (including Cancer)
- Frailty
- Geriatric Oncology
- Toxicity
- Gastric cancer
- Oesophageal cancer
Fingerprint
Dive into the research topics where Mark Baxter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 4 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Establishing DNA Damage Response-Deficient (DDRD) Status in Patients with Advanced Oesophageal Adenocarcinoma who have had an Exceptional Response to First Line Chemotherapy
Baxter, M., Petty, R. & Walsh, S.
1/03/19 → 31/08/19
Project: Research
Research Output
-
1690P Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19
Lee, R., Zhou, C., Shotton, R., Tivey, A., Dickens, E., Huddar, P., Mckenzie, H., Boyce, H., Maynard, A., Rowe, M. P., Khan, S., Eastlake, L., Angelakas, A., Baxter, M., Copson, E., Horsley, L., Thomas, A., Wilson, C., Cooksley, T. & Armstrong, A., Sep 2020, In : Annals of Oncology. 31, Supplement 4, p. S999 1 p.Research output: Contribution to journal › Meeting abstract › peer-review
-
Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma
Baxter, M., Spender, L. & Petty, R., 22 Sep 2020, In : British Journal of Cancer. 2 p.Research output: Contribution to journal › Editorial › peer-review
-
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Oct 2020, In : Lancet Oncology. 21, 10, p. 1309-1316 8 p.Research output: Contribution to journal › Article › peer-review
13 Citations (Scopus) -
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed
Meemanage, M., Spender, L. C., Collinson, D., Iannetta, J., Challapalli, P., Turbitt, J., Clark, C., Baxter, M., Murray, G., Walsh, S., Miedzybrodzka, Z. & Petty, R. D., 9 Nov 2020, In : Cancer Chemotherapy and Pharmacology. 17 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Metastatic cutaneous deposits as the initial feature of rectal adenocarcinoma
Sadler, K. A., Baxter, M. A., Peters, A. L. & Grose, D., 1 Feb 2020, In : Scottish Medical Journal. 65, 1, p. 28-31 4 p.Research output: Contribution to journal › Article › peer-review